Home  |  Contact
Due to scheduled maintenance work, this service will not be available from Tuesday August 23rd 06:00 pm until Wednesday August 24th 08:00 am CEST. Apologies for the inconvenience.

UniProtKB/Swiss-Prot Q8N2Y8: Variant p.Thr73Ala

AP-4 complex accessory subunit RUSC2
Gene: RUSC2
Variant information

Variant position:  73
The position of the amino-acid change on the UniProtKB canonical protein sequence.

Type of variant:  LB/B
The variants are classified into three categories: LP/P, LB/B and US.
  • LP/P: likely pathogenic or pathogenic.
  • LB/B: likely benign or benign.
  • US: uncertain significance

Residue change:  From Threonine (T) to Alanine (A) at position 73 (T73A, p.Thr73Ala).
Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.

Physico-chemical properties:  Change from medium size and polar (T) to small size and hydrophobic (A)
The physico-chemical property of the reference and variant residues and the change implicated.

BLOSUM score:  0
The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another:
  • Lowest score: -4 (low probability of substitution).
  • Highest score: 11 (high probability of substitution).
More information can be found on the following page

Other resources:  
Links to websites of interest for the variant.

Sequence information

Variant position:  73
The position of the amino-acid change on the UniProtKB canonical protein sequence.

Protein sequence length:  1516
The length of the canonical sequence.

The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.

Residue conservation: 
The multiple alignment of the region surrounding the variant against various orthologous sequences.



Sequence annotation in neighborhood:  
The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:
  • Type: the type of sequence feature.
  • Positions: endpoints of the sequence feature.
  • Description: contains additional information about the feature.

Chain 1 – 1516 AP-4 complex accessory subunit RUSC2
Region 33 – 105 Disordered
Compositional bias 57 – 82 Polar residues

Literature citations

Prediction of the coding sequences of unidentified human genes. VII. The complete sequences of 100 new cDNA clones from brain which can code for large proteins in vitro.
Nagase T.; Ishikawa K.; Nakajima D.; Ohira M.; Seki N.; Miyajima N.; Tanaka A.; Kotani H.; Nomura N.; Ohara O.;
DNA Res. 4:141-150(1997)

DNA sequence and analysis of human chromosome 9.
Humphray S.J.; Oliver K.; Hunt A.R.; Plumb R.W.; Loveland J.E.; Howe K.L.; Andrews T.D.; Searle S.; Hunt S.E.; Scott C.E.; Jones M.C.; Ainscough R.; Almeida J.P.; Ambrose K.D.; Ashwell R.I.S.; Babbage A.K.; Babbage S.; Bagguley C.L.; Bailey J.; Banerjee R.; Barker D.J.; Barlow K.F.; Bates K.; Beasley H.; Beasley O.; Bird C.P.; Bray-Allen S.; Brown A.J.; Brown J.Y.; Burford D.; Burrill W.; Burton J.; Carder C.; Carter N.P.; Chapman J.C.; Chen Y.; Clarke G.; Clark S.Y.; Clee C.M.; Clegg S.; Collier R.E.; Corby N.; Crosier M.; Cummings A.T.; Davies J.; Dhami P.; Dunn M.; Dutta I.; Dyer L.W.; Earthrowl M.E.; Faulkner L.; Fleming C.J.; Frankish A.; Frankland J.A.; French L.; Fricker D.G.; Garner P.; Garnett J.; Ghori J.; Gilbert J.G.R.; Glison C.; Grafham D.V.; Gribble S.; Griffiths C.; Griffiths-Jones S.; Grocock R.; Guy J.; Hall R.E.; Hammond S.; Harley J.L.; Harrison E.S.I.; Hart E.A.; Heath P.D.; Henderson C.D.; Hopkins B.L.; Howard P.J.; Howden P.J.; Huckle E.; Johnson C.; Johnson D.; Joy A.A.; Kay M.; Keenan S.; Kershaw J.K.; Kimberley A.M.; King A.; Knights A.; Laird G.K.; Langford C.; Lawlor S.; Leongamornlert D.A.; Leversha M.; Lloyd C.; Lloyd D.M.; Lovell J.; Martin S.; Mashreghi-Mohammadi M.; Matthews L.; McLaren S.; McLay K.E.; McMurray A.; Milne S.; Nickerson T.; Nisbett J.; Nordsiek G.; Pearce A.V.; Peck A.I.; Porter K.M.; Pandian R.; Pelan S.; Phillimore B.; Povey S.; Ramsey Y.; Rand V.; Scharfe M.; Sehra H.K.; Shownkeen R.; Sims S.K.; Skuce C.D.; Smith M.; Steward C.A.; Swarbreck D.; Sycamore N.; Tester J.; Thorpe A.; Tracey A.; Tromans A.; Thomas D.W.; Wall M.; Wallis J.M.; West A.P.; Whitehead S.L.; Willey D.L.; Williams S.A.; Wilming L.; Wray P.W.; Young L.; Ashurst J.L.; Coulson A.; Blocker H.; Durbin R.M.; Sulston J.E.; Hubbard T.; Jackson M.J.; Bentley D.R.; Beck S.; Rogers J.; Dunham I.;
Nature 429:369-374(2004)

The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).
The MGC Project Team;
Genome Res. 14:2121-2127(2004)

Disclaimer: Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.